Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Kyowa Kirin’s Q1 Sales Tick Up as North America Revenue Counters Japan Dip
May 7, 2020
- Fujifilm to Carry Out Process Development, Manufacturing of COVID-19 Treatment for Anti-COVID-19 Initiative
May 7, 2020
- Gilead Files Remdesivir for COVID-19 in Japan
May 4, 2020
- Sanofi Warns of QT Prolongation for Plaquenil after FDA/EMA Flag Risks in COVID-19
May 1, 2020
- Taisho Licenses HIF-PH Inhibitor to US Biotech for Age-Related Diseases
May 1, 2020
- Mitsubishi Tanabe Drops Seasonal Flu Vaccine Project in US, Canadian Plan Intact
April 30, 2020
- Wakamoto, Rohto Forge Comprehensive Biz Tie-Up
April 30, 2020
- Shionogi’s Novel Antibiotic Cefiderocol Approved in Europe
April 30, 2020
- Astellas, Harvard Seal 3-Year Research Alliance Pact
April 30, 2020
- Chugai Plans May Enrollment Start for Actemra COVID-19 Trial, Aims for Approval by Year-End
April 30, 2020
- Mitsuka to Bow Out from Mitsubishi Tanabe Board
April 30, 2020
- Bayer Japan Ethical Drug Sales Grow 4.2% in 2019
April 30, 2020
- Sanofi Japan to Ensure Drug Supplies, Employees’ Safety at the Same Time in COVID-19 Crisis: Chief
April 30, 2020
- AZ to Divest 4 Off-Patent Drugs to Taiyo Pharma
April 30, 2020
- Lilly’s 3 Tadalafil Products Transferred to Nippon Shinyaku
April 30, 2020
- Sumitomo Dainippon Ups FY2019 Guidance on Brisk North America, Japan Biz
April 30, 2020
- Takeda’s Mobocertinib Bags FDA Breakthrough Therapy Status for EGFR Exon 20 Mutant NSCLC
April 30, 2020
- Sumitomo Dainippon, Nihon Generic Pulling Some Metformin Products over Carcinogen Risks
April 28, 2020
- Daiichi Sankyo Sees 30% Growth for Edoxaban, Strong Enhertu Uptick in FY2019
April 28, 2020
- GSK, MICIN to Test Online Medical Exams and Medication Guidance for Improving Adherence in Asthma Patients
April 28, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…